ID

14132

Beschreibung

A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.; ODM derived from: https://clinicaltrials.gov/show/NCT01928368

Link

https://clinicaltrials.gov/show/NCT01928368

Stichworte

Versionen (2)
  1. 31.03.16 31.03.16 -
  2. 20.09.21 20.09.21 -
Hochgeladen am

31. März 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Asthma NCT01928368

Englisch

Eligibility Asthma NCT01928368

1 Formulare  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT01928368
Criteria
Beschreibung

Criteria

is a current non-smoker, has not used any nicotine or tobacco containing products (including but not limited to: snuff, chewing tobacco, cigars, cigarettes, pipes, or nicotine patches) within the last 6 months, and cumulative smoking history is ≤10 pack years.
Beschreibung

Non-smoker

Datentyp

boolean

Alias
UMLS CUI [1]
C0337672
UMLS CUI [2]
C0037390
UMLS CUI [3]
C0008038
UMLS CUI [4]
C0678446
UMLS CUI [5]
C0677453
UMLS CUI [6]
C0240766
UMLS CUI [7]
C0358855
UMLS CUI [8]
C2230126
females must be of documented non-reproductive potential (ie, postmenopausal [see definition below]; or history of hysterectomy; or history of bilateral salpingectomy; or history of bilateral oophorectomy).
Beschreibung

Female | Postmenopausal state | Hysterectomy | bilateral salpingectomy | Bilateral oophorectomy

Datentyp

boolean

Alias
UMLS CUI [1]
C0015780
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0232970
UMLS CUI [3]
C0020699
UMLS CUI [4]
C2243030
UMLS CUI [5]
C0278321
body mass index (bmi) between ≥ 18.0 and ≤ 32.0 kg/m2 at screening. (subjects with mild atopic asthma only)
Beschreibung

Mild allergic asthma | Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C4040757
UMLS CUI [2]
C1305855
documented history of mild, stable atopic asthma within 2 years of screening.
Beschreibung

Mild allergic asthma | Stable status

Datentyp

boolean

Alias
UMLS CUI [1,1]
C4040757
UMLS CUI [1,2]
C0205360
has used only inhaled short-acting β2-agonists (less than twice weekly) to treat asthma.
Beschreibung

Therapeutic procedure | Asthma | Adrenergic beta-2 Receptor Agonists

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0004096
UMLS CUI [2]
C2936789
pre-bronchodilator forced expiratory volume in 1 second (fev1) > 70 percent predicted at screening.
Beschreibung

FEV1 | pre-bronchodilator

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0748133
UMLS CUI [1,2]
C2599602
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
(all subjects)
Beschreibung

ID.7

Datentyp

boolean

history or evidence of a clinically significant disorder, condition or disease that, in the opinion of the principal investigator or amgen medical monitor would pose a risk to subject safety or interfere with the study evaluation, procedures, or completion.
Beschreibung

Disease | Study Subject Participation Status | Limited

Datentyp

boolean

Alias
UMLS CUI [1]
C0012634
UMLS CUI [2,1]
C2348568
UMLS CUI [2,2]
C0439801
subject has a history of residential exposure to tuberculosis without a documented history of prophylactic treatment of tuberculosis or subject has a positive purified protein derivative (ppd) or quantiferon test at screening. subjects with a documented negative ppd or quantiferon test within 4 weeks prior to screening who have no known tuberculosis exposure and have not traveled to an area with tuberculosis do not need to have a test performed at screening.
Beschreibung

Exposure to tuberculosis | positive purified protein derivative (ppd) | Quantiferon test

Datentyp

boolean

Alias
UMLS CUI [1]
C0149796
UMLS CUI [2]
C0199176
UMLS CUI [3]
C0032739
UMLS CUI [4,1]
C1875713
UMLS CUI [4,2]
C0392366
has donated or lost ≥ 500 ml of blood or plasma within 8 weeks of administration of the first dose of ip.
Beschreibung

Blood Donation | Blood Loss | Immunoprecipitation

Datentyp

boolean

Alias
UMLS CUI [1]
C0005794
UMLS CUI [2]
C3163616
UMLS CUI [3]
C0021069
other criteria may apply.
Beschreibung

Other criteria

Datentyp

boolean

Alias
UMLS CUI [1]
C0205394
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Asthma NCT01928368

1 Formulare
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT01928368
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Non-smoker
Item
is a current non-smoker, has not used any nicotine or tobacco containing products (including but not limited to: snuff, chewing tobacco, cigars, cigarettes, pipes, or nicotine patches) within the last 6 months, and cumulative smoking history is ≤10 pack years.
boolean
C0337672 (UMLS CUI [1])
C0037390 (UMLS CUI [2])
C0008038 (UMLS CUI [3])
C0678446 (UMLS CUI [4])
C0677453 (UMLS CUI [5])
C0240766 (UMLS CUI [6])
C0358855 (UMLS CUI [7])
C2230126 (UMLS CUI [8])
Female | Postmenopausal state | Hysterectomy | bilateral salpingectomy | Bilateral oophorectomy
Item
females must be of documented non-reproductive potential (ie, postmenopausal [see definition below]; or history of hysterectomy; or history of bilateral salpingectomy; or history of bilateral oophorectomy).
boolean
C0015780 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0232970 (UMLS CUI [2,2])
C0020699 (UMLS CUI [3])
C2243030 (UMLS CUI [4])
C0278321 (UMLS CUI [5])
Mild allergic asthma | Body mass index
Item
body mass index (bmi) between ≥ 18.0 and ≤ 32.0 kg/m2 at screening. (subjects with mild atopic asthma only)
boolean
C4040757 (UMLS CUI [1])
C1305855 (UMLS CUI [2])
Mild allergic asthma | Stable status
Item
documented history of mild, stable atopic asthma within 2 years of screening.
boolean
C4040757 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
Therapeutic procedure | Asthma | Adrenergic beta-2 Receptor Agonists
Item
has used only inhaled short-acting β2-agonists (less than twice weekly) to treat asthma.
boolean
C0087111 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
C2936789 (UMLS CUI [2])
FEV1 | pre-bronchodilator
Item
pre-bronchodilator forced expiratory volume in 1 second (fev1) > 70 percent predicted at screening.
boolean
C0748133 (UMLS CUI [1,1])
C2599602 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
ID.7
Item
(all subjects)
boolean
Disease | Study Subject Participation Status | Limited
Item
history or evidence of a clinically significant disorder, condition or disease that, in the opinion of the principal investigator or amgen medical monitor would pose a risk to subject safety or interfere with the study evaluation, procedures, or completion.
boolean
C0012634 (UMLS CUI [1])
C2348568 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
Exposure to tuberculosis | positive purified protein derivative (ppd) | Quantiferon test
Item
subject has a history of residential exposure to tuberculosis without a documented history of prophylactic treatment of tuberculosis or subject has a positive purified protein derivative (ppd) or quantiferon test at screening. subjects with a documented negative ppd or quantiferon test within 4 weeks prior to screening who have no known tuberculosis exposure and have not traveled to an area with tuberculosis do not need to have a test performed at screening.
boolean
C0149796 (UMLS CUI [1])
C0199176 (UMLS CUI [2])
C0032739 (UMLS CUI [3])
C1875713 (UMLS CUI [4,1])
C0392366 (UMLS CUI [4,2])
Blood Donation | Blood Loss | Immunoprecipitation
Item
has donated or lost ≥ 500 ml of blood or plasma within 8 weeks of administration of the first dose of ip.
boolean
C0005794 (UMLS CUI [1])
C3163616 (UMLS CUI [2])
C0021069 (UMLS CUI [3])
Other criteria
Item
other criteria may apply.
boolean
C0205394 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video